Literature DB >> 13514500

Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia.

J H FELLMAN.   

Abstract

Entities:  

Keywords:  CENTRAL NERVOUS SYSTEM/pathology; EPINEPHRINE/metabolism; PHENYLPYRUVIC OLIGOPHRENIA/physiology

Mesh：

Substances：

Year:  1958        PMID： 13514500      PMCID： PMC497295          DOI： 10.1136/jnnp.21.1.58

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  13 in total

1.  Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria.

Authors:  M D ARMSTRONG; F H TYLER
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  Demonstration of tyrosinase in melanocytes of the human hair matrix by autoradiography.

Authors:  A KUKITA; T B FITZPATRICK
Journal:  Science       Date:  1955-06-24       Impact factor: 47.728

3.  The concentration of adrenaline in human plasma and its relation to mental activity.

Authors:  H WEIL-MALHERBE
Journal:  J Ment Sci       Date:  1955-10

4.  Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria.

Authors:  T B FITZPATRICK; M MIYAMOTO
Journal:  Nature       Date:  1957-01-26       Impact factor: 49.962

5.  A possible mechanism for disturbance in tyrosine metabolism in phenylpyruvic oligophrenia.

Authors:  J DANCIS; M E BALIS
Journal:  Pediatrics       Date:  1955-01       Impact factor: 7.124

6.  Detection of some new abnormal metabolites in the urine of phenylketonuria.

Authors:  R J BOSCOTT; H BICKEL
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

7.  Phenylpyruvic oligophrenia deficiency of phenylalanine-oxidizing system.

Authors:  G A JERVIS
Journal:  Proc Soc Exp Biol Med       Date:  1953-03

8.  Noradrenaline and the suprarenal medulla.

Authors:  D M SHEPHERD; G B WEST
Journal:  Br J Pharmacol Chemother       Date:  1951-12

9.  Excretion of conjugated phenylacetic acid in phenylketonuria.

Authors:  L I WOOLF
Journal:  Biochem J       Date:  1951-06       Impact factor: 3.857

10.  Fluorimetric determination of adrenaline in blood; a new sensitive and specific method.

Authors:  A LUND
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1949-10
View more
  4 in total

Review 1.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

2.  Neuropathology of Rett syndrome.

Authors:  K Jellinger; D Armstrong; H Y Zoghbi; A K Percy
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Dopa and dopamine in the pigment of Substantia nigra.

Authors:  L Nordgren; H Rorsman; A M Rosengren; E Rosengren
Journal:  Experientia       Date:  1971-10-15

4.  Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria.

Authors:  M L Bauman; T L Kemper
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.